APRICUS BIOSCIENCES INC - COM NEW (APRI)

CUSIP: 03832V307

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class
Equity / COM NEW
Total 13F shares
6,493,090
Share change
+3,454,961
Total reported value
$2,634,738
Price per share
$0.41
Number of holders
20
Value change
+$1,269,974
Number of buys
13
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 03832V307?
CUSIP 03832V307 identifies APRI - APRICUS BIOSCIENCES INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of APRICUS BIOSCIENCES INC - COM NEW (APRI) as of Q1 2018

As of 31 Mar 2018, APRICUS BIOSCIENCES INC - COM NEW (APRI) was held by 20 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,493,090 shares. The largest 10 holders included ARMISTICE CAPITAL, LLC, SABBY MANAGEMENT, LLC, Sarissa Capital Management LP, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, CITADEL ADVISORS LLC, Healthcare Value Capital, LLC, BlackRock Inc., FRANKLIN RESOURCES INC, and Squarepoint Ops LLC. This page lists 20 institutional shareholders reporting positions in this security for the Q1 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.